Superbugs and You: Recent Episodes
CIDRAP/Antimicrobial Resistance Fighter Coalition
Infections caused by highly drug-resistant bacteria, or “superbugs,” are becoming more and more common, making antimicrobial resistance one of the world’s greatest health threats. In fact, infections caused by superbugs are projected to reach epidemic levels within our lifetimes. Drug-resistant infections can affect anyone, and we are all at risk.
This podcast series will address this global crisis through conversations with patients, clinicians, and researchers to discover how superbugs are affecting people and healthcare systems globally. And we’ll highlight actions the average citizen can take today to make sure the drugs we already have stay effective, in order to protect ourselves, our families, and our communities.
<p><strong>Season 4 of Superbugs and You is here!</strong></p><p>Episode 16: One Health is a concept that recognizes this interconnection and emphasizes the need for collaborative approaches to solving the issue of antimicrobial resistance at all levels - humans, animals, and the environment is undeniable. Guests on this episode include Lance Price, (George Washington University), Francisco Diez-Gonzales (University of Georgia), and Paul Plummer (Iowa State University).</p><p> </p>
<p><strong>Season 4 of Superbugs and You is here!</strong></p><p>Episode 15: Antimicrobials are the cornerstone of modern medicine, and this is especially true for patients with cystic fibrosis. People with CF rely on antibiotics for recurring and persistent infections, and with regular use, antibiotics become less and less effective in fighting these infections. Guests include Ella Balasa, (Patient Advocate), Helen Boucher, MD (Tufts Medicine), and Mary Booth Dwight (Cystic Fibrosis Foundation).</p><p> </p>
<p><strong>Season 4 of Superbugs and You is here!</strong></p><p>Episode 14: This year, Italy leads the Presidency of the G7. The group is united by common values in addressing global challenges, including antimicrobial resistance. This episode features Italian leaders driving transformational policy to battle AMR. Guests include Francesca Chiara, (CIDRAP ASP), Mariano Votta (Active Citizenship Network-Cittadinanzattiva), Damiano De Felice (CARB-X), and Massimo Sartelli (Global Alliance for Infections in Surgery).</p><p> </p>
<p>Health officials around the world are sounding the alarm on a highly infectious bacteria causing extensively drug-resistant infections. <em>Shigella</em>, which causes the infection known as shigellosis, is a genus of bacteria that results in gastrointestinal distress that ranges from uncomfortable to deadly, in adults and children. Global surveillance efforts on<em> Shigella</em> have identified outbreaks of strains that are extensively drug-resistant across the UK, US, and parts of Europe. How is the world dealing with this new superbug?</p><p> </p><p><strong>Guests</strong></p><p><strong>Lou Bourgeois, PhD:</strong> Johns Hopkins, Science Officer for Enteric and Diarrheal Diseases, PATH</p><p><strong>Gauri Godbole, MBBS, MD:</strong> UKHSA, Consultant Microbiologist and Parasitologist, Hospital for Tropical Diseases, University College London Hospitals, NHS</p><p><strong>Naemah Logan, MD:</strong> Medical Officer, Surveillance Epidemiologist, National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), Centers for Disease Control and Prevention (CDC)</p><p><strong>Louise Francois Watkins, MD:</strong> Medical Officer, NARMS, Centers for Disease Control and Prevention: CDC</p><p> </p>
<p> </p><p>Over the past decade, several strains (types) of <em>Salmonella typhi</em> have become resistant to multiple antibiotics. Resistant strains have been identified across the globe. However, the 2018 launch of a vaccine has slowed infections. It is estimated that TCV introduction with a catch-up campaign will avert 42.5 million cases and 506,000 deaths caused by fluoroquinolone-resistant typhoid fever, and 21.2 million cases and 342,000 deaths from multidrug-resistant typhoid fever over 10 years following introduction. This episode will cover the impact of vaccinations and the challenges to deploy effective programs. </p><p> </p><p><strong>Guests:</strong></p><ul><strong>Farah Naz Qamar </strong>-<strong> </strong>Pediatric Infectious Disease Associate Professor, The Aga Khan University, Pakistan<br><strong>Kathy Neuzil </strong>- Director of the Center for Vaccine Development and Global Health, University of Maryland School of Medicine<br><strong>Denise Garrett </strong>- Vice President, Applied Epidemiology, Sabin Vaccine Institute<br><strong>Calman MacLennan </strong>- Senior Program Officer, Bacterial Vaccines, Bill and Melinda Gates Foundation</ul><p> </p><p>For more information on the impact of typhoid conjugate vaccines and AMR, check out CIDRAP-ASP's report, <a href="https://www.cidrap.umn.edu/antimicrobial-stewardship/cidrap-asp-report-vaccine-bridge">A Vaccine Is a Bridge: The New Era of Typhoid Prevention</a>.</p>
<p>Despite great improvements in mortality for children under 5, sepsis remains a leading cause of death in young children. The highest incidence and mortality were seen in newborns, with the biggest impact seen in low- and middle-income countries in sub-Saharan Africa and Asia. This episode will highlight how the availability of guidelines, diagnostics, and therapeutics can make a difference in the smallest of patients. Content warning: this episode contains discussions of infant loss.</p><p><strong>Guests:</strong></p><ul><strong>Kamala Thiagarajan</strong> - Freelance journalist, Global health and environmental sciences<br><strong>Seamus O’Brien</strong> - Director of Research and Development, Global Antibiotic Research and Development Program<br><strong>Phoebe Williams</strong> - Pediatrician, Infectious Disease Physician, Faculty of Medicine, University of Sydney</ul><p><strong>Materials Mentioned in this Episode</strong></p><ul><a href="https://www.bbc.com/future/article/20220927-neonatal-sepsis-the-new-threat-posed-by-superbugs#:~:text=Now%20a%20new%20enemy%20is,the%20face%20of%20raging%20infections.">Neonatal sepsis: the new threat posed by superbugs</a>, Kamala Thiagarajan, BBC<br><a href="https://pubmed.ncbi.nlm.nih.gov/36466207/">Antibiotics needed to treat multidrug-resistant infections in neonates</a>, Phoebe Williams, …, Seamus O’Brien et al., Bulletin of the World Health Organization</ul>
<p>Around the world, the multidrug resistant and pan-resistantfungus <em>Candida auris</em> has caused outbreaks in healthcare systems. While it is now highlighted by CDC as an urgent threat, only six years ago there were no reports of resistant <em>C. auris</em> strains that were able to spread easily between patients. These infections are challenging to treat a with 5% — 10% of colonized patients going on to develop invasive infections. This episode will cover how these outbreaks have impacted patients, healthcare systems, and continued efforts to better understand and slow the impact of these infections.</p><p><strong>Guests:</strong></p><ul><strong>Tom M Chiller</strong> - Chief, Mycotic Diseases Branch, Centers for Disease Control and Prevention<br><strong>Andrew Jacobs</strong> - Reporter, Health and Science desk, The New York Times<br><strong>Bhavarth Shukla</strong> - Associate Professor, Division of Infectious Diseases, University of Miami</ul><p><strong>Materials Mentioned in this Episode</strong></p><ul><a href="https://www.nytimes.com/2019/04/06/health/drug-resistant-candida-auris.html">A Mysterious Infection, Spanning the Globe in a Climate of Secrecy</a>, Matt Richtel and Andrew Jacobs, The New York Times<br><a href="https://www.cdc.gov/drugresistance/covid19.html">2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance</a>, Centers for Disease Control and Prevention</ul>
<p>Defined as an “urgent” AMR threat by the US CDC, resistant <em>Acinetobacter baumanii </em>cause deadly infections and are difficult to remove from the environment. <em>Acinetobacter </em>is resistant to many antibiotics and is a frequent cause of hospital acquired infections. In the 2022 Lancet publication on drug-resistant infections (GRAM report), it was identified as the leading pathogen causing mortality in Southeast Asia. This episode will cover how infections caused by resistant <em>Acinetobacter</em> impact patients and on how new treatments are making an impact.</p><h4><strong>Guests:</strong></h4><ul><strong>Steffanie Strathdee</strong> - Associate Dean of Global Health Sciences, University of California San Diego School of Medicine; Author, <a href="https://theperfectpredator.com/"><em>The Perfect Predator</em></a><br><strong>Greg Merril</strong> - CEO, Adaptive Phage Therapeutics<br><strong>Patrick McGann</strong> - Deputy Director, Multidrug-Resistant Organism Repository and Surveillance Network (MRSN)<br><strong>Jason Bennett </strong>- Director, MRSN; Associate Professor of Medicine, Walter Reed Army Institute of Research</ul>
<p>Join us for a sneak peak of Season 3 of Superbugs and You by listening to a portion of our interview with Dr. Tom Chiller, Chief of the Mycotic Diseases Branch at the Centers for Disease Control and Prevention, discussing <em>Candida auris</em>.</p>
Neisseria gonorrhoeae is the second most common bacterial sexually transmitted infection in the world, and it has become a superbug. It has developed resistance to every antibiotic currently approved for treatment, and multidrug-resistant strains have been identified globally. Hear from clinicians advocating for their patients, a global leader, and a leading expert in drug development on actions needed to combat resistant gonorrhea.
Learn more about our guests this episode: Teodora Wi: https://www.who.int/campaigns/world-antimicrobial-awareness-week/2018/features-from-around-the-world/super-gonorrhoea-q-a-with-dr.-teodora-wi Matthew Hamill: https://www.hopkinsmedicine.org/profiles/details/matthew-hamill Yuka Manabe: https://www.hopkinsmedicine.org/profiles/details/yukari-manabe Edward Hook: https://apps.medicine.uab.edu/FacultyDirectory/FacultyData.asp?FID=7333
This podcast is co-created by CIDRAP-ASP and the Antimicrobial Resistance Fighter Coalition (ARFC).
Theme music
Artist: Derek Sandbeck Song Title: Power Plugs & Superbugs
In this episode, we will explore the ways that antimicrobial resistance impacts treatment for some of the most vulnerable patients, such as those undergoing cancer treatment or receiving bone marrow transplants. A recent survey of oncologists showed that 95% of them worry about the impact of superbugs on the future of cancer treatments, and one in five patients receiving chemotherapy will have a bacterial infection. In this episode, you will hear directly from a patient who had a bacterial infection while fighting cancer, from front-line clinicians, and from a researcher driving policy at a national level.
Learn more about our guests this episode: Russell McGowan: https://www.emedevents.com/speaker-profile/russell-mcgowan Catherine Liu: https://www.fredhutch.org/en/faculty-lab-directory/liu-catherine.html Frank Tverdek: https://twitter.com/ftverdek?lang=en David Hyun: https://www.pewtrusts.org/en/about/experts/david-hyun
This podcast is co-created by CIDRAP-ASP and the Antimicrobial Resistance Fighter Coalition (ARFC).
Theme music
Artist: Derek Sandbeck Song Title: Power Plugs & Superbugs
Clostridioides difficile (also known as C. diff or CDI) can cause deadly diarrhea. It is the most common healthcare-associated infection in the United States and rates of infections are rising globally. In this episode, we hear how a young Mom was impacted by the disease, how leading healthcare organizations are driving best practice guidelines, and how the US CDC is tracking this superbug.
Learn more about our guests this episode: Christina Fuhrman: https://antimicrobialresistancefighters.org/stories/story-christina-fuhrman Cliff McDonald: https://blogs.cdc.gov/safehealthcare/dr-mcdonald/ Libby Dodds Ashley: https://medicine.duke.edu/faculty/elizabeth-dodds-ashley-pharmd
This podcast is co-created by CIDRAP-ASP and the Antimicrobial Resistance Fighter Coalition (ARFC).
Theme music
Artist: Derek Sandbeck Song Title: Power Plugs & Superbugs
Methicillin-resistant S. aureus (MRSA) is found in the community and in healthcare systems. According to the WHO, hospitalized patients with MRSA infections are 64% more likely to die than people with drug-sensitive infections. It can be difficult to treat. In this episode, hear from a patient who battled an infection for years, a infectious disease clinician who shares his daily challenges, and a researcher who using an unique approach to find the next antibiotic.
Learn more about our guests this episode: Vanessa Carter: https://vanessacarter.co.za/ Andrew Morris: https://trp.utoronto.ca/person/andrew-morris Jo Handelsman: https://wid.wisc.edu/people/jo-handelsman/
This podcast is co-created by CIDRAP-ASP and the Antimicrobial Resistance Fighter Coalition (ARFC).
Theme music
Artist: Derek Sandbeck Song Title: Power Plugs & Superbugs
In Season 2 of Superbugs and You, we continue to focus on the threat of antimicrobial resistance, which occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to antibiotics and other medicines. In other words, they become “Superbugs”.
This season, we will focus on Methicillin-resistant Staphylococcus aureus, Clostridioides difficile infections, resistant Neisseria gonorrhoeae, and the impact of antimicrobial resistance on modern medicine. Each episode will feature discussions with patients, physicians, and scientists to find out what’s causing antimicrobial resistance, how it affects the lives of ordinary people, and most importantly, what we can do to stop it. Subscribe for new episodes beginning on October 20th!
This podcast is co-created by the Center for Infectious Disease Research & Policy (CIDRAP) and the Antimicrobial Resistance Fighter Coalition.
Visit the CIDRAP Antimicrobial Stewardship Project website: https://www.cidrap.umn.edu/asp
Visit the Antimicrobial Resistance Fighter Coalition website: https://antimicrobialresistancefighters.org/
Theme music Artist: Derek Sandbeck Song Title: Power Plugs & Superbugs
In this final episode of Season 1, we discuss how the COVID-19 pandemic has impacted strategies to address antimicrobial resistance. Our guests will describe the patient experience of surviving COVID, the role of antimicrobial stewardship in managing COVID patients, and how the COVID-19 pandemic potentiates AMR and emerging approaches to the surveillance, treatment and prevention of AMR.
Learn more about our guests this week:
Dr. Marilyn Stebbins: https://pharmacy.ucsf.edu/news/2020/04/my-covid-19-journey
Dr. Ryan Stevens: https://www.idstewardship.com/contributors/ryan-stevens-pharm-d-bcps-bcidp/
Dr. Manica Balasegaram: https://gardp.org/team/manica-balasegaram/
This podcast is co-created by the Center for Infectious Disease Research & Policy (CIDRAP) and the Antimicrobial Resistance Fighter Coalition (ARFC).
This podcast is available on Apple Podcasts, Spotify, and Google Podcasts.
In this episode, we discuss the global issue of multidrug-resistant tuberculosis or TB. Our guests in this episode will describe living with TB, and the experience of managing these difficult-to-treat infections. They will also examine the role that social structures, local governance, accessible and affordable treatments, and patient advocacy play in tuberculosis transmission and management.
Learn more about our guests this week:
Paulina Siniatkina: https://www.paulinarts.com/about Natalie Schellack: https://theconversation.com/profiles/natalie-schellack-315771 Mark Nicol: https://www.uwa.edu.au/profile/mark-nicol
This podcast is co-created by the Center for Infectious Disease Research & Policy (CIDRAP) and the Antimicrobial Resistance Fighter Coalition (ARFC).
This podcast is available on Apple Podcasts, Spotify, and Google Podcasts. Tune in weekly for new episodes!
In this episode, we discuss sepsis and the challenge of an infection caused by a drug-resistant microorganism. Our guests describe the long-term patient experience of surviving and living with a sepsis diagnosis, as well as the current diagnosis and treatment options for sepsis. Finally, we discuss global approaches for new treatments, and the need for advocacy and awareness.
Learn more about our guests this week:
Mary Millard: https://marymillard.org/
Dr. Vance Fowler: https://medicine.duke.edu/faculty/vance-garrison-fowler-md
Dr. Konrad Reinhart: https://patientsafetymovement.org/speaker/konrad-reinhart/
This podcast is co-created by the Center for Infectious Disease Research & Policy (CIDRAP) and the Antimicrobial Resistance Fighter Coalition (ARFC).
This podcast is available on Apple Podcasts, Spotify, and Google Podcasts. Tune in weekly for new episodes!
In this episode we discuss the global impact of multidrug-resistant gram-negative bacterial infections. Our guests in this episode will describe the experience of living through, diagnosing, and managing these difficult-to-treat infections.
Learn more about our guests this week:
David Ricci: https://www.statnews.com/2019/12/31/antibiotic-resistance-nearly-killed-me/ Dr. John Lynch: https://aid.uw.edu/faculty/john-b-lynch-md-mph
Dr. Laura Piddock: https://gardp.org/team/laura-piddock/
This podcast is co-created by the Center for Infectious Disease Research & Policy (CIDRAP) and the Antimicrobial Resistance Fighter Coalition (ARFC).
This podcast is available on Apple Podcasts, Spotify, and Google Podcasts. Tune in weekly for new episodes!
Infections caused by highly drug resistant bacteria, or “superbugs,” are becoming more and more common, making antimicrobial resistance one of the world’s greatest health threats. Drug-resistant infections can affect anyone, and we are all at risk.
In this podcast miniseries, we will dig deeper into this global crisis through fascinating conversations with patients, clinicians, and researchers. We’ll also highlight actions the average citizen can take today to make sure the drugs we already have stay effective, in order to protect ourselves, our families, and our communities.
Subscribe for new episodes beginning on November 24th!
This podcast is co-created by the Center for Infectious Disease Research & Policy (CIDRAP) and the Antimicrobial Resistance Fighter Coalition.
Visit the CIDRAP Antimicrobial Stewardship Project website: https://www.cidrap.umn.edu/asp
Visit the Antimicrobial Resistance Fighter Coalition website: https://antimicrobialresistancefighters.org/